{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:08:16Z","timestamp":1790665696278,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/pas.0000000000000473","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T11:49:34Z","timestamp":1435837774000},"page":"1322-1330","source":"Crossref","is-referenced-by-count":71,"title":["Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling"],"prefix":"10.1097","volume":"39","author":[{"given":"Ji","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mottok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Rimsza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Delabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Braziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":". Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (Groupe dEtude des Lymphomes de lAdulte) study.","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdj030","article-title":". Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.","volume":"17","author":"Savage","year":"2006","journal-title":"Ann Oncol"},{"key":"R4-3-20210131","first-page":"1258","article-title":". Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.","volume":"87","author":"Zinzani","year":"2002","journal-title":"Haematologica"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":". Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":". The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"R7-3-20210131","first-page":"549","article-title":". Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30 Hodgkin cells.","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":". Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene.","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":". Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line.","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":". Mediastinal gray zone lymphoma: the missing link between classic Hodgkins lymphoma and mediastinal large B-cell lymphoma.","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1200\/JCO.1999.17.8.2479","article-title":". CNS involvement in primary mediastinal large B-cell lymphoma.","volume":"17","author":"Bishop","year":"1999","journal-title":"J Clin Oncol"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.leu.2404919","article-title":". Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).","volume":"21","author":"Wessendorf","year":"2007","journal-title":"Leukemia"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":". Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":". Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":". Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2010.32.8401","article-title":"Molecular pathogenesis of Hodgkins lymphoma: increasing evidence of the importance of the microenvironment.","volume":"29","author":"Steidl","year":"2011","journal-title":"J Clin Oncol"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1084\/jem.180.4.1329","article-title":". Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.","volume":"180","author":"Silacci","year":"1994","journal-title":"J Exp Med"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":". MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2011-05-326538","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma.","volume":"118","author":"Steidl","year":"2011","journal-title":"Blood"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":". The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":". Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/PAS.0000000000000297","article-title":". Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain.","volume":"38","author":"Shi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.1997.15.4.1646","article-title":". Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.","volume":"15","author":"Lazzarino","year":"1997","journal-title":"J Clin Oncol"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2012-06-437210","article-title":". Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene.","volume":"121","author":"Saarinen","year":"2013","journal-title":"Blood"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/ajot.2001.24828","article-title":"Dermal thymus: case report and review of the literature.","volume":"22","author":"Hiraumi","year":"2001","journal-title":"Am J Otolaryngol"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":". CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1023\/A:1011195708834","article-title":". Among diffuse large B-cell lymphomas, T-cell-richhistiocyte-rich BCL and CD30 anaplastic B-cell subtypes exhibit distinct clinical features.","volume":"12","author":"Maes","year":"2001","journal-title":"Ann Oncol"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":". Cooperative epigenetic modulation by cancer amplicon genes.","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":". Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:16Z","timestamp":1620967516000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201510000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000473","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}